Published in Blood Weekly, February 24th, 1997
Umbilical cord blood has received much attention recently as doctors look to it as an alternative to bone marrow for transplantation. Umbilical cord blood is a rich source of stem cells, the building blocks of the blood and immune system, and has been used in the treatment of a variety of cancers and blood diseases.
Already, over 300 cord blood transplants have been performed worldwide, and cord blood appears to cause less rejection and result in improved patient outcomes when compared to bone marrow,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.